FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
202057NDAAMARIN PHARMS001VASCEPACAPSULE;ORAL1GMICOSAPENT ETHYL2012-07-26PrescriptionYes
002VASCEPACAPSULE;ORAL500MGICOSAPENT ETHYL2012-07-26PrescriptionNo
083242ANDAAMARIN PHARMS001AMENTABLET;ORAL10MGMEDROXYPROGESTERONE ACETATE1974-05-15DiscontinuedNo